U S Physical Therapy Inc /nv (USPH): Lawrance W Mcafee , Chief Financial Officer of U S Physical Therapy Inc /nv sold 4,000 shares on May 6, 2016. The Insider selling transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were sold at $54.90 per share for a total value of $219,600.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 15, 2016, Jerald L Pullins (director) sold 5,000 shares at $51.35 per share price.On Mar 8, 2016, Lawrance W Mcafee (Chief Financial Officer) sold 5,000 shares at $52.74 per share price.Also, On Dec 31, 2015, Clayton Trier (director) sold 4,500 shares at $55.23 per share price.On Nov 20, 2015, Christopher J Reading (Chief Executive Officer) sold 25,000 shares at $52.10 per share price.
U.S. Physical Therapy: On Friday, May 6, 2016 heightened volatility was witnessed in U.S. Physical Therapy which led to swings in the share price. The shares opened for trading at $51.91 and hit $56.75 on the upside , eventually ending the session at $56.48, with a gain of 8.97% or 4.65 points. The heightened volatility saw the trading volume jump to 3,36,700 shares. The 52-week high of the share price is $56.75 and the company has a market cap of $706 M . The 52-week low of the share price is at $42.59.
Company has been under the radar of several Street Analysts.U.S. Physical Therapy is Upgraded by Barrington Research to Outperform and the brokerage firm has set the Price Target at $58. Earlier the firm had a rating of Mkt Perform on the company shares. The Rating was issued on May 6, 2016.U.S. Physical Therapy is Downgraded by Jefferies to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Mar 1, 2016.
U.S. Physical Therapy Inc. through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders sports-related injuries preventative care rehabilitation of injured workers and neurological-related injuries. The Company primarily operates through subsidiary clinic partnerships in which it owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company provides services at its clinics on an outpatient basis. Patients are treated for approximately one hour per day two to three times a week for two to six weeks. The Company operates approximately 489 clinics in 42 states of the United States.